top of page

Revolutionizing Pharmacovigilance: Cutting-Edge Automation Use Cases


An impressive 86% of pharmaceutical companies are planning to significantly boost their investments in automation technologies over the next five years. This shift highlights the industry's movement towards utilizing cutting-edge solutions to manage regulatory challenges, improve safety measures, and streamline operations.


Moreover, organizations embracing automation have observed notable benefits: 42% reported quicker compliance with regulatory standards, while 37% saw substantial reductions in time-to-market for new treatments. These outcomes demonstrate how automation can expedite decision-making and enhance productivity.


For years, automation has been revolutionizing pharmacovigilance, aiding Life Sciences organizations in achieving greater efficiency, improved global compliance, and more informed decision-making throughout the safety lifecycle. Now, it's time to explore advanced technologies—such as GenAI and LLMs—that promise even more transformative results.


Here, we explore several key use cases highlighted by industry experts, showcasing how Datacreds’ advanced automation and GenAI-enabled solutions are delivering exceptional ROI.


1.Unparalleled Case Intake Efficiency

A leading organization streamlined their case intake process using structured field mapping and workflow automation. This upgrade achieved complete automation, greatly minimizing manual input and enhancing efficiency, accuracy, and speed. As a result, intake times were reduced by 60% and accuracy improved by 40%.


2.Optimized Follow-Up for Adverse Event Reports

Another prominent company implemented an automated query module to centralize and streamline follow-up operations. This system automates reminders, creates questions in multiple languages, and manages follow-ups from a single platform. The result is reduced manual effort, improved oversight, and increased response rates. These enhancements led to a 50% decrease in follow-up time and a 30% boost in response rates.


3.Enhanced Adverse Event Reporting Through System Integrations

A leading firm integrated their CRM system with Datacreds’ MultiVigilance, streamlining the adverse event reporting process. Sales reps can now enter data directly into the CRM, which is automatically synced with the adverse events database. This integration minimizes manual data entry, boosting efficiency and reducing errors. As a result, data entry errors decreased by 45% and reporting efficiency improved by 35%.


4.Improved Accuracy and Consistency in Compliance Through Distribution Rule Management

Another major player automated their distribution management system. This system manages rule changes, product additions, and distribution workflows, ensuring compliance with regulatory requirements and enhancing traceability while minimizing the risk of under or over-reporting. This has led to a 70% reduction in manual compliance checks and a 55% improvement in reporting accuracy.


5.Enhanced Benefit-Risk Assessments and Signal Validation

Another major player automated their distribution management system, which now handles rule changes, product additions, and distribution workflows. This automation ensures regulatory compliance, enhances traceability, and reduces the risk of under- or over-reporting. Consequently, manual compliance checks have been reduced by 70%, and reporting accuracy has improved by 55%.


Automation is revolutionizing operational excellence in the pharmaceutical industry. Datacreds’ advanced technology suite provides a variety of cutting-edge automation solutions that deliver cost and time savings while producing significant results throughout the safety lifecycle. In an industry where speed, accuracy, and compliance are essential, embracing automation is key to staying competitive and achieving impactful outcomes for patients worldwide.


Eager to Leverage the Power of Automation?

Discover how Datacreds’ innovative solutions can revolutionize your pharmaceutical operations. Visit our website, request a demo, or contact our experts today to embrace the future of pharmaceutical excellence.

Comments


bottom of page